[1]
2022. Combined immune-mediated adverse events in treatment with immune checkpoint inhibitors. Voprosy onkologii. 68, 6 (Dec. 2022), 846–853. DOI:https://doi.org/10.37469/0507-3758-2022-68-6-846-853.